Literature DB >> 22268316

A 63-year-old man with hypomagnesaemia and seizures.

Nirmalan Arulanantham1, Mark Anderson, Neil Gittoes, Robin E Ferner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22268316      PMCID： PMC4952343          DOI： 10.7861/clinmedicine.11-6-591

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

1.  Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-11-28       Impact factor: 2.953

Review 2.  Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.

Authors:  Simone Janett; Pietro Camozzi; Gabriëlla G A M Peeters; Sebastiano A G Lava; Giacomo D Simonetti; Barbara Goeggel Simonetti; Mario G Bianchetti; Gregorio P Milani
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

3.  Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.

Authors:  Jonathan Zipursky; Erin M Macdonald; Simon Hollands; Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Nina Lathia; David N Juurlink
Journal:  PLoS Med       Date:  2014-09-30       Impact factor: 11.069

4.  The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia.

Authors:  Yong Ting Tai; Chin Vong Tong
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-04-20

5.  Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory.

Authors:  Tigran Makunts; Sama Alpatty; Kelly C Lee; Rabia S Atayee; Ruben Abagyan
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.